Valuation: Control Bionics Limited

Market Cap 3.05Cr 2.13Cr 1.87Cr 1.73Cr 1.58Cr 3Cr 205.67Cr 21Cr 8.08Cr 100.43Cr 8.02Cr 7.84Cr 346.74Cr P/E 2024
-1.4x
P/E 2025 -1.3x
Enterprise Value 3.02Cr 2.12Cr 1.85Cr 1.71Cr 1.57Cr 2.97Cr 204.07Cr 20Cr 8.02Cr 100Cr 7.95Cr 7.78Cr 344.04Cr EV / Sales 2024
1.92x
EV / Sales 2025 1.4x
Free-Float
54.68%
Yield 2024 *
-
Yield 2025 -
1 day-5.41%
1 week-5.41%
Current month-5.41%
1 month-23.08%
3 months+12.90%
6 months-6.67%
Current year+14.75%
1 week 0.07
Extreme 0.068
0.08
1 month 0.07
Extreme 0.068
0.09
Current year 0.05
Extreme 0.05
0.1
1 year 0.03
Extreme 0.032
0.1
3 years 0.03
Extreme 0.026
0.1
5 years 0.03
Extreme 0.026
0.74
10 years 0.03
Extreme 0.026
1.24
Manager TitleAgeSince
Chief Executive Officer - 19/01/2023
Director of Finance/CFO - 13/05/2024
Chief Tech/Sci/R&D Officer - 01/01/2014
Director TitleAgeSince
Chairman 66 19/11/2025
Director/Board Member - 19/01/2023
Director/Board Member - 01/04/2023
Change 5-day change 1-year change 3-year change Capi.($)
-5.41%-5.41%+84.21%-17.65% 2.13Cr
-0.16%+5.87%+17.90%-19.73% 1.76TCr
-3.55%+2.88%+17.43%+95.22% 173.47Cr
-0.33%+4.59%-33.84%-78.06% 124.31Cr
-1.19%-7.28%-38.03%+13.79% 102.42Cr
+1.98%+8.94%-24.06%-50.67% 66Cr
+2.44%+6.67%-36.74%-54.14% 56Cr
+0.88%+0.84%+39.23%-52.51% 45Cr
+0.47%+3.08%-52.89%-58.27% 39Cr
+0.89%+1.34%-23.86%-26.48% 34Cr
Average -0.36%+2.63%-5.06%-24.85% 240.53Cr
Weighted average by Cap. -0.32%+9.33%+9.13%-16.01%

Financials

2024 2025
Net sales 53.51L 37.46L 32.75L 30.28L 27.79L 52.59L 36Cr 3.61Cr 1.42Cr 18Cr 1.41Cr 1.38Cr 61Cr 61.45L 43.02L 37.61L 34.78L 31.91L 60.4L 41Cr 4.15Cr 1.63Cr 20Cr 1.62Cr 1.58Cr 70Cr
Net income -59.14L -41.4L -36.19L -33.47L -30.71L -58.13L -40Cr -3.99Cr -1.57Cr -19Cr -1.55Cr -1.52Cr -67Cr -61.09L -42.77L -37.38L -34.57L -31.73L -60.04L -41Cr -4.12Cr -1.62Cr -20Cr -1.61Cr -1.57Cr -69Cr
Net Debt -96.95T -67.88T -59.33T -54.87T -50.35T -95.29T -65.4L -7L -3L -31.94L -3L -2L -1.1Cr -2L -2L -1L -1L -1L -2L -1.6Cr -16.01L -6L -78.16L -6L -6L -2.7Cr
Logo Control Bionics Limited
Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and Amyotrophic Lateral Sclerosis. Its products include Control Bionics Trilogy Systems, NeuroStrip, NeuroNode, Cosmos Connect and accessories. NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as electromyography output. This output is then sent wirelessly via NeuroNode to a personal computer, enabling speech and other computer-controlled functions like email and texting. Its technology is integrated with eye gaze technology whereby the eye gaze enables a cursor to be moved about a computer screen, driven much like a mouse and the NeuroNode acts like a mouse button. It is commercializing its advancement in its technology, NeuroStrip. It is focused on neuromuscular rehabilitation and athletic optimization.
Employees
-
Date Price Change Volume
16/26/16 A$0.0700 -5.41% 22,53,176
15/26/15 A$0.0740 -1.33% 5,30,059
14/26/14 A$0.0750 0.00% 10,35,306
13/26/13 A$0.0750 +2.74% 2,30,680
10/26/10 A$0.0730 +4.29% 1,94,998

Annual profits - Rate of surprise